Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 5240 of 6351
-
Experimental combo therapy for brain metastases shows early safety signals
Symptom relief Stopped earlyThis phase I trial finds out the side effects and possible benefits of stereotactic radiosurgery and immune checkpoint inhibitors with NovoTTF-100M for the treating of melanoma that has spread to the brain (brain metastases). Stereotactic radiosurgery is a type of external radiat…
Phase 1 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Promising cream for painful skin condition tested in tiny trial
Disease control Stopped earlyInvestigators hypothesize that ruxolitinib 1.5% cream is an effective therapy for HS participants through inhibition of inflammatory activity. Investigators aim to: * Demonstrate the clinical efficacy of ruxolitinib 1.5% cream in decreasing the clinical disease activity after 1…
Phase 2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Latino teens with depression: which help strategy works best?
Knowledge-focused Recruiting nowDespite experiencing higher rates of depressive symptoms (Center for Disease Control and Prevention, 2020) and similar rates of Major Depressive Disorder (MDD; Substance Abuse and Mental Health Services Administration (SAMHSA), 2019), Latino adolescents in the U.S. are significan…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Teen cannabis study seeks clues to relapse in brain chemistry
Knowledge-focused OngoingThis project seeks to learn more about the effects of cannabis use on the endocannabinoid system and endogenous opioid systems in adolescents to address a fundamental gap in knowledge and identify biomarkers that may help distinguish youth who relapse from youth who remain sober.
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New injection for rheumatoid arthritis enters first human safety tests
Disease control CompletedThis is a randomized, double-blind, placebo-controlled, first-in-human phase I study. It consists of a single ascending dose part in healthy subjects (Part 1) and in patients with rheumatoid arthritis (Part 2) as well as a multiple dose part in healthy subjects (Part 3). The stud…
Phase 1 • Sponsor: Lipum AB • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Teaching back: a new way to help trauma patients remember?
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate whether receiving education after trauma surgeries affects three things: 1) knowledge about injury and treatment ("recall"), 2) how well patients follow treatment recommendations, and 3) how satisfied patients are with their care. To do so…
Sponsor: University Hospitals Cleveland Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Tennis therapy: a new way to boost confidence in early psychosis?
Symptom relief CompletedThis study involves two groups of participants: one participating in an intervention focused on self-esteem-and thus primarily psychological-and the other on self-esteem and tennis-and thus involving physical activity. The objectives of this study are to document participants' ex…
Sponsor: Centre Hospitalier Esquirol • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New study aims to unlock secrets of systemic sclerosis through patient samples
Knowledge-focused Recruiting nowThis study corresponds to a monocentric prospective cohort of adult patients with systemic sclerosis. It will allow the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood samples, as well as stool sa…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Power up your knees: new exercise program aims to beat chronic kneecap pain
Symptom relief OngoingThe objective of this study is to compare a novel 6-week strength training rehabilitation incorporating power exercises (STRIPE) program to a standard of care (SOC) program on short-term and long-term pain, subjective function, patellofemoral pain recurrence rates, and secondary …
Sponsor: University of Connecticut • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New MRI study seeks hidden stroke causes in rare blood disorder
Knowledge-focused By invitation onlyAntiphospholipid syndrome (APS) is an important cause of young stroke which could result in major disability. Cohort studies suggested that 17% of young ischemic stroke were accountable by APS (1). Although warfarin has been the mainstay of treatment in APS for the past decades, …
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Could a common diabetes drug slow cataracts?
Knowledge-focused OngoingDetermination of concentrations of systemically applied metformin in human lens capsule and its ability to lower the proliferation rate of human lens epithelial cells in vitro.
Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:29 UTC
-
New painkiller injection enters first human tests
Symptom relief CompletedPart A Primary objective: • To evaluate the safety, tolerability, and pharmacokinetic profile of a single dose of YZJ-4729 tartrate injection. Secondary objectives: * To investigate the PK/PD profile of YZJ-4729 tartrate injection administered as a single dose; * To investiga…
Phase 1 • Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Heparin-Coated Stent-Graft under the microscope: new analysis of nearly 1,000 patients
Knowledge-focused CompletedTo evaluate the effectiveness of the VSX device in pre-determined patient populations to understand the patient characteristics that impact outcomes.
Sponsor: Rijnstate Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Blueberry powder may strengthen immunity in seniors
Symptom relief CompletedThis research study will test the effects of Blueberries on immune functions in overweight older men and postmenopausal women
Sponsor: Loma Linda University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Which stitch is faster and safer for gastric bypass?
Symptom relief CompletedThe study is designed as a prospective, mono-centric, randomized, patient blinded comparison of unidirectional barbed suture (Symmcora® mid term, UBS) vs. a conventional suture (Novosyn®, CS). Patient will be randomly allocated in a 1:1 ratio to either the UBS group or the CS gro…
Sponsor: Aesculap AG • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Cancer care at home: what do patients and doctors really think?
Knowledge-focused Recruiting nowThe objective of this qualitative research study is to assess the knowledge, attitudes and beliefs of cancer care providers, patients with cancer and caregivers regarding hospital care at home. We aim to conduct qualitative interviews to inform implementation of future on oncolog…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Long COVID brain fog study tracks Real-World treatment outcomes
Knowledge-focused CompletedLongitudinal study collecting retrospective and prospective data on treatments received and change in quality of life among patients with neurocognitive symptoms attending a Long COVID clinic
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Could a tailored Check-Up schedule improve life after head and neck cancer?
Knowledge-focused Stopped earlyThere is an ongoing debate about the optimal duration, frequency and extent of follow-up (FU) after treatment with curative intent (aimed at complete cure) in patients with head and neck cancer (HNC). The present study aims to answer these questions and thus provide a scientifica…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
New study checks bleeding risk when CLL drug meets blood thinners
Disease control CompletedThe goal of CICERO is to investigate the clinical outcome with a particular focus on prospective data on safety using acalabrutinib (+/- obinutuzumab) in CLL patients receiving co-medication with DOACs (edoxaban, rivaroxaban, dabigatran, apixaban) irrespective of treatment line.
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Kidney function may change how diabetes drug works
Knowledge-focused CompletedThis study used a single-dose, open design to compare the pharmacokinetics of subjects with mild, moderate and severe renal insufficiency and end-stage renal disease and subjects with normal renal function.
Phase 1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC